Standard Chem & Pharm CO., LTD. (1720.TW)
TWD 57.4
(2.32%)
TWD 57.4
(2.32%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 11.18 Billion TWD | 2.01% |
| 2022 | 10.96 Billion TWD | 8.55% |
| 2021 | 10.1 Billion TWD | 43.33% |
| 2020 | 7.04 Billion TWD | 1.75% |
| 2019 | 6.92 Billion TWD | 7.59% |
| 2018 | 6.43 Billion TWD | 1.02% |
| 2017 | 6.37 Billion TWD | 2.38% |
| 2016 | 6.22 Billion TWD | 7.43% |
| 2015 | 5.79 Billion TWD | 7.83% |
| 2014 | 5.37 Billion TWD | 0.4% |
| 2013 | 5.35 Billion TWD | 4.49% |
| 2012 | 5.12 Billion TWD | 5.29% |
| 2011 | 4.86 Billion TWD | 7.67% |
| 2010 | 4.51 Billion TWD | 17.57% |
| 2009 | 3.84 Billion TWD | 8.34% |
| 2008 | 3.54 Billion TWD | 7.36% |
| 2007 | 3.3 Billion TWD | -5.25% |
| 2006 | 3.48 Billion TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 11.57 Billion TWD | 3.42% |
| 2024 Q2 | 11.76 Billion TWD | 1.71% |
| 2023 Q4 | 11.18 Billion TWD | 2.15% |
| 2023 FY | 11.18 Billion TWD | 2.01% |
| 2023 Q1 | 10.99 Billion TWD | 0.29% |
| 2023 Q2 | 11.21 Billion TWD | 1.96% |
| 2023 Q3 | 10.95 Billion TWD | -2.33% |
| 2022 Q2 | 10.79 Billion TWD | 8.05% |
| 2022 FY | 10.96 Billion TWD | 8.55% |
| 2022 Q4 | 10.96 Billion TWD | -1.79% |
| 2022 Q3 | 11.16 Billion TWD | 3.46% |
| 2022 Q1 | 9.99 Billion TWD | -1.12% |
| 2021 Q1 | 7.32 Billion TWD | 3.89% |
| 2021 FY | 10.1 Billion TWD | 43.33% |
| 2021 Q3 | 7.41 Billion TWD | 0.33% |
| 2021 Q4 | 10.1 Billion TWD | 36.34% |
| 2021 Q2 | 7.38 Billion TWD | 0.86% |
| 2020 Q3 | 6.83 Billion TWD | -0.31% |
| 2020 FY | 7.04 Billion TWD | 1.75% |
| 2020 Q1 | 6.95 Billion TWD | 0.37% |
| 2020 Q4 | 7.04 Billion TWD | 3.15% |
| 2020 Q2 | 6.85 Billion TWD | -1.41% |
| 2019 Q4 | 6.92 Billion TWD | 0.97% |
| 2019 FY | 6.92 Billion TWD | 7.59% |
| 2019 Q3 | 6.86 Billion TWD | 4.85% |
| 2019 Q2 | 6.54 Billion TWD | -1.29% |
| 2019 Q1 | 6.62 Billion TWD | 2.96% |
| 2018 FY | 6.43 Billion TWD | 1.02% |
| 2018 Q4 | 6.43 Billion TWD | 1.56% |
| 2018 Q3 | 6.33 Billion TWD | -1.36% |
| 2018 Q2 | 6.42 Billion TWD | 1.5% |
| 2018 Q1 | 6.33 Billion TWD | -0.65% |
| 2017 Q2 | 6.3 Billion TWD | 3.22% |
| 2017 Q4 | 6.37 Billion TWD | 0.94% |
| 2017 FY | 6.37 Billion TWD | 2.38% |
| 2017 Q3 | 6.31 Billion TWD | 0.2% |
| 2017 Q1 | 6.1 Billion TWD | -1.93% |
| 2016 FY | 6.22 Billion TWD | 7.43% |
| 2016 Q2 | 5.84 Billion TWD | 0.03% |
| 2016 Q3 | 6.05 Billion TWD | 3.5% |
| 2016 Q4 | 6.22 Billion TWD | 2.88% |
| 2016 Q1 | 5.84 Billion TWD | 0.85% |
| 2015 Q1 | 5.37 Billion TWD | -0.03% |
| 2015 Q4 | 5.79 Billion TWD | 7.03% |
| 2015 FY | 5.79 Billion TWD | 7.83% |
| 2015 Q3 | 5.41 Billion TWD | 0.13% |
| 2015 Q2 | 5.4 Billion TWD | 0.63% |
| 2014 FY | 5.37 Billion TWD | 0.4% |
| 2014 Q4 | 5.37 Billion TWD | 0.04% |
| 2014 Q3 | 5.37 Billion TWD | -2.03% |
| 2014 Q2 | 5.48 Billion TWD | 1.43% |
| 2014 Q1 | 5.4 Billion TWD | 1.0% |
| 2013 Q2 | 5.13 Billion TWD | -2.47% |
| 2013 Q1 | 5.26 Billion TWD | 2.86% |
| 2013 FY | 5.35 Billion TWD | 4.49% |
| 2013 Q3 | 5.04 Billion TWD | -1.82% |
| 2013 Q4 | 5.35 Billion TWD | 6.08% |
| 2012 Q3 | 4.78 Billion TWD | -1.61% |
| 2012 Q1 | 4.76 Billion TWD | -2.14% |
| 2012 FY | 5.12 Billion TWD | 5.29% |
| 2012 Q4 | 5.12 Billion TWD | 7.01% |
| 2012 Q2 | 4.86 Billion TWD | 2.18% |
| 2011 Q1 | 4.59 Billion TWD | 1.62% |
| 2011 Q4 | 4.86 Billion TWD | 6.78% |
| 2011 Q3 | 4.55 Billion TWD | -1.91% |
| 2011 Q2 | 4.64 Billion TWD | 1.16% |
| 2011 FY | 4.86 Billion TWD | 7.67% |
| 2010 FY | 4.51 Billion TWD | 17.57% |
| 2010 Q4 | 4.51 Billion TWD | 0.0% |
| 2009 FY | 3.84 Billion TWD | 8.34% |
| 2008 FY | 3.54 Billion TWD | 7.36% |
| 2007 FY | 3.3 Billion TWD | -5.25% |
| 2006 FY | 3.48 Billion TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Grape King Bio Ltd | 15.51 Billion TWD | 27.87% |
| Maywufa Company Ltd. | 2.83 Billion TWD | -295.072% |
| ScinoPharm Taiwan, Ltd. | 11.72 Billion TWD | 4.546% |
| Lotus Pharmaceutical Co., Ltd. | 32.99 Billion TWD | 66.086% |
| LIWANLI Innovation Co., Ltd. | 834.17 Million TWD | -1241.295% |
| YungShin Global Holding Corporation | 11.51 Billion TWD | 2.812% |
| PhytoHealth Corporation | 2.35 Billion TWD | -376.012% |
| SCI Pharmtech, Inc. | 6.69 Billion TWD | -67.227% |
| Formosa Laboratories, Inc. | 13.63 Billion TWD | 17.948% |
| PharmaEssentia Corporation | 27.26 Billion TWD | 58.97% |
| Bora Pharmaceuticals Co., LTD. | 25.05 Billion TWD | 55.338% |